aTyr Pharma ATYR Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's operating lease liabilities (current)?
- aTyr Pharma (ATYR) reported operating lease liabilities (current) of $890K in Q1 2026.
- How has aTyr Pharma's operating lease liabilities (current) changed year-over-year?
- aTyr Pharma's operating lease liabilities (current) increased by 20.3% year-over-year, from $740K to $890K.
- What is the long-term trend for aTyr Pharma's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), aTyr Pharma's operating lease liabilities (current) has grown at a -0.6% compound annual growth rate (CAGR), from $861K to $836K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.